Mircette (Desogestrel / Ethinyl estradiol)

Mircette (Desogestrel / Ethinyl Estradiol): Comprehensive Guide for Australian Patients

Basic Product Information

Mechanism of Action

• Simple terms: Mircette contains two hormones—desogestrel (a progestogen) and ethinyl estradiol (an oestrogen)—which work together to prevent ovulation (release of an egg from the ovary) and thicken cervical mucus, making it harder for sperm to reach the egg.
• For specialists: Mircette acts primarily by suppressing gonadotropin secretion at the hypothalamic-pituitary level, thus inhibiting follicular development and ovulation. Desogestrel converts to its active metabolite etonogestrel, while ethinyl estradiol reinforces endometrial stability.

Pharmacokinetics

• Absorption: Both active components are well absorbed (bioavailability 60–80%) after oral ingestion.
• Distribution: Both compounds are highly protein-bound in plasma.
• Metabolism: Desogestrel is rapidly metabolised in the liver to etonogestrel; ethinyl estradiol undergoes first-pass hepatic metabolism.
• Elimination: Metabolites excreted primarily in urine and faeces. The terminal half-life is approximately 24–30 hours for desogestrel’s active metabolite; about 24 hours for ethinyl estradiol.
• Duration of Action: To maintain full contraceptive effect, daily dosing at the same time each day is required.

Use in Everyday Life and Best Practices

Typical Dosage and How to Use

• Usual dose: Take one tablet at the same time each day for 21 days, followed by a 7-day tablet-free interval (or placebo/“inactive” tablets, depending on the brand).
• Start on the first day of your menstrual period for immediate contraceptive protection, or on any day with additional protection (e.g. condoms) for the first 7 days, if not starting with your period.
• Swallow tablet whole with water; do not chew or crush.
• Maintain a consistent schedule, which fits your lifestyle—mornings or evenings.
• Missed a tablet? Follow the patient information leaflet or consult your pharmacist as instructions vary depending on when the dose was missed.
• Mircette does not protect against sexually transmitted infections (STIs).

Australian Context

• Available across Australia with a prescription from a GP, women’s health clinic, or telehealth service.
• Some states offer pharmacist-initiated ongoing supply for existing users.
• Used commonly by women under 50 seeking reliable contraception or cycle regularity.

Dosing in the Morning vs Evening

• Morning dosing: May help form a habit alongside other morning routines; possibly reduces risk of stomach upset for some.
• Evening dosing: Suits those with shift work or later routines. Alcohol intake in the evening may increase chances of missing a dose – set multiple reminders.
• Tips for Regularity: Set daily alarms. Use a pillbox. Pair with another habit (e.g. tooth brushing).

Taking with Food or on an Empty Stomach

• Mircette can be taken with or without food.
• Some women may find that taking it with food reduces mild stomach upset or nausea, especially when starting therapy.
• No evidence that typical Australian meals (dairy- or gluten-containing) affect absorption or efficacy.
• If gastrointestinal upset occurs or if you vomit within 3-4 hours of taking a tablet, take another dose as soon as possible and continue as usual.

Interaction Warnings

Indications

Dosing According to Clinical Indications

Safety Profile / Side Effects

• Common Side Effects
  • Bloating, breast tenderness, headache
  • Nausea or mild abdominal discomfort
  • Breakthrough bleeding or spotting (usually during first months of use)
  • Mood changes, mild weight fluctuation
• Rare/Serious Warnings
  • Venous thromboembolism (VTE): Higher risk in smokers, older age, obesity
  • High blood pressure, liver dysfunction
  • Severe allergic reaction (<1/10,000 cases)
  • Possible increased risk of breast/cervical cancer (small but significant)
• Warnings & Precautions
  • Do NOT use if you have a history of blood clots, severe migraine with aura, unexplained vaginal bleeding, or liver disease
  • Not suitable during pregnancy; discontinue if pregnancy is suspected
  • Inform your doctor if breastfeeding; another form may be preferable

Guidelines for Proper Use

• Take your tablet at the same time every day to maintain effect
• If you miss a tablet, follow the instructions in your pack carefully. If in doubt—especially after 12+ hours—use a barrier method for 7 days
• See your GP or women’s health nurse for an annual review
• Chat to your pharmacist about interactions with over-the-counter medicines or supplements
• Store in a cool, dry place (below 30°C); do not use past expiry date
• If you experience any severe or unusual side effect, seek medical advice promptly

Alternative Treatment Options

• Other reimbursed contraceptive options (PBS-listed):
  • Combined oral contraceptives: Levlen, Microgynon, Yasmin, Yaz
  • Progestogen-only pills: Microlut, Noriday
  • Long-acting options: Implanon (implant), Depo-Provera (injection), Mirena/Kyleena (IUDs)
• Comparative overview:
  • Combined pills (like Mircette): Best for cycle control; not suitable for women with migraine with aura or VTE history
  • Progestogen-only methods: Lower VTE risk; must be taken at a consistent time (pills); may cause unpredictable bleeding
  • LARCs (Long-acting reversible contraceptives): Highly effective, low maintenance, cost-effective; require procedure for insertion/removal

Legal, Registration, and Reimbursement Status in Australia

• Legal classification: Schedule 4: Prescription only
• Regulatory bodies: Therapeutic Goods Administration (TGA), Pharmaceutical Benefits Scheme (PBS)
• Registration: Registered for contraception; other uses off-label as per clinical discretion
• Reimbursement: Many combined oral contraceptives, including Mircette-equivalents, are subsidised by the PBS; consult your pharmacist regarding co-payments

Latest Research and Clinical Guidance (2022–2025)

• Recent Australian clinical guidelines (Family Planning Alliance Australia, 2024) support the safety and efficacy of desogestrel/ethinyl estradiol for contraception in healthy, non-smoking women under 50.
• 2023 systematic review (Australian and New Zealand Journal of Obstetrics and Gynaecology) confirmed low absolute VTE risk despite relative increase compared to non-users
• Ongoing studies on personalisation of pill choice based on clotting profile, BMI, and migraine history
• References: FPAA Clinical Handbook 2024; ANZJOG Vol 64(2); TGA Medicines Safety Updates 2023–2025

Availability and Delivery

• *As of June 2024, concessional prices for eligible patients (check PBS for updates).
• Available from most community and online pharmacies Australia-wide; prescription required.

Frequently Asked Questions (FAQ)

1. Will Mircette protect me from sexually transmitted infections (STIs)?
   No, Mircette and other oral contraceptives do not protect against STIs. Condoms should be used for protection against STIs.
2. What should I do if I miss a tablet?
   Take the missed tablet as soon as you remember. If it is more than 12 hours late, there may be a drop in efficacy—use backup contraception (e.g. condoms) for the following 7 days and follow the patient leaflet or ask your pharmacist.
3. Can I use Mircette while breastfeeding?
   Combined oral contraceptives are not recommended during the first 6 weeks after birth and may reduce milk supply. Consider progestogen-only methods; speak with your GP for personalised advice.
4. What are the most common side effects?
   The most common are mild nausea, breast tenderness, breakthrough bleeding, and headaches, especially during the first months of use.
5. Does Mircette increase my risk of blood clots?
   There is a slightly increased risk of blood clots with all combined contraceptives, especially if you smoke or have other risk factors. Discuss your personal risk with your doctor.